chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Allergy to vaccines; Had ICP; platelets dropped to 2; Almost died from MMR vaccine; This spontaneous report has been received from a registered nurse concerning a 4-year-old male patient. The patient's pertinent medical history, concurrent conditions, previous drug allergies or reactions, and concomitant medications were not reported.   On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) as prophylaxis (strength, dose, vaccination schedule, route and anatomical site of administration, lot number, and expiration date were not reported).    On an unknown date, the patient almost died from measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) vaccine (vaccination complication). In addition, the patient experienced allergy to vaccines, for which he was two weeks hospitalized. On an unknown date, the patient had intracranial pressure increased (ICP) and his platelets dropped to 2 (units not provided) (platelet count decreased). The patient was advised by the pediatrician to never take another vaccine, and at the reporting time, the patient had 24-year-old and still had a significant allergy to vaccines (not recovered). The outcome of vaccination complication, platelet count decreased, and intracranial pressure increased were not reported.   The reporter considered allergy to vaccine and vaccination complication to be related to Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (manufacturer unknown). The causality assessment between the suspect therapy administration and the events of platelet count decreased, and intracranial pressure increased was not reported.   The event vaccination complication was considered to be a life-threatening event by the reporter. Furthermore, upon internal review the event of intracranial pressure increased was considerer to be medically significant.
At 2pm, I felt very tired like I hadn't slept all night with warm rosy cheeks-low fever.  I took an 800mg and went to bed, woke up the next morning feeling great with no reactions.
9/26 - 8pm - Extreme fatigue. 9/27 - Noon - woke up fatigued, lips tingling and edematous, eyes and hands edematous. Took BENADRYL and RIMIDINE - steadily dosed herself. 9/28 - Noon - very lethargic and "frail". Unable to stand from kneeling, diarrhea. Continued BENADRYL. 9/29 - Started feeling better.
Severe rash, extremity and forehead swelling rash consistent with urticaria vs erythema multiforme arising 3 days after initiation of Amoxil (2nd course since birth).
Headache, tightness of chest, trouble breathing, numbness in right arm and leg, dizziness, and elevated blood pressure. Went to the ER and was given an EKG, chest X-Ray and CT scan. Blood work was drawn and came back with a high D-Dimer. No clots were found so I was sent to my PCP.  More blood was drawn and D-diner was still elevated. Sent to hematologist for more test. Leg Doppler and echocardiogram was also administered. Waiting on MRI for my head. Starting on 8/31/2021, headache followed by numbness to the left side of my face surfaced. Chest is still tight and I often feel like I am having heart palpitations.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. No information about the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On an unknown dates, the patients were administered an unspecified number of improperly stored doses of PEDVAXHIB lot # L012835, expiration date 11-MAR-2018 (dose and route of administration were not reported). No adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
Headache; A lot of fatigue; Carpal tunnel had flared up; Generalized weakness; Left side of my neck hurt; Ear ache; Right knee became swollen; Hands feel numb until I touch my fingers; Touch my fingers I get a prickly feeling; Thumb on right has arthritis and became swollen; Arthritic joints flared up; Injection site arm became swollen; This spontaneous case was reported by a consumer and describes the occurrence of CARPAL TUNNEL SYNDROME (Carpal tunnel had flared up), ASTHENIA (Generalized weakness), NECK PAIN (Left side of my neck hurt), EAR PAIN (Ear ache) and JOINT SWELLING (Right knee became swollen) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Carpal tunnel syndrome. Concurrent medical conditions included Finger arthritis and Arthritis.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE SWELLING (Injection site arm became swollen). On 23-Mar-2021, the patient experienced CARPAL TUNNEL SYNDROME (Carpal tunnel had flared up), ASTHENIA (Generalized weakness), NECK PAIN (Left side of my neck hurt), EAR PAIN (Ear ache), JOINT SWELLING (Right knee became swollen), HYPOAESTHESIA (Hands feel numb until I touch my fingers), PARAESTHESIA (Touch my fingers I get a prickly feeling), PERIPHERAL SWELLING (Thumb on right has arthritis and became swollen), ARTHRITIS (Arthritic joints flared up), HEADACHE (Headache) and FATIGUE (A lot of fatigue). The patient was treated with PREDNISONE at an unspecified dose and frequency. On 30-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, CARPAL TUNNEL SYNDROME (Carpal tunnel had flared up), ASTHENIA (Generalized weakness), NECK PAIN (Left side of my neck hurt), EAR PAIN (Ear ache), JOINT SWELLING (Right knee became swollen), HYPOAESTHESIA (Hands feel numb until I touch my fingers), PARAESTHESIA (Touch my fingers I get a prickly feeling), PERIPHERAL SWELLING (Thumb on right has arthritis and became swollen), ARTHRITIS (Arthritic joints flared up), VACCINATION SITE SWELLING (Injection site arm became swollen) and FATIGUE (A lot of fatigue) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment includes long term Steroid medication.   This case was linked to US-MODERNATX, INC.    MOD-2021-067380 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Significant: Symptoms redeveloped again & prescribed longterm steroid medication; Sender's Comments:  US-MODERNATX, INC.    MOD-2021-067380:1st dose AE
PTIENT COMPLAINED OF REDNESS NEAR SITE OF INJECTION. REDNESS EXTENDED FROM SHOULDER AT INJECTION SITE DOWN TO BELOW ELBOW. PATIENT ALSO STATED THAT THERE WAS PAIN CONTINUING IN TO THE EVENING AFTER INJECTION AT INJECTION SITE
administration of Havrix expired dose; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 54-year-old female patient who received HAV (Havrix) (batch number X9A9B, expiry date 14th June 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 5th July 2022, the patient received Havrix (intramuscular) and Havrix Pre-Filled Syringe Device. On 5th July 2022, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 7-Jul-2022 Reporter's comment: The pharmacist reported that the patient was administered a dose of Havrix in left arm which was expired on 14th June 2022. The reporter consented to follow-up. Additional supportive information: The patient received an expired dose of Havrix, which led to expired vaccine used. This was 2 out of 2 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022103864:Same reporter. Patient 1
Tested positive for COVID-19; This is a spontaneous report from a contactable consumer (patient) from the Pfizer-sponsored program, . A 24-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in the right arm on 14Mar2021 (Batch/Lot Number: EN6206) as 1ST DOSE, SINGLE DOSE for COVID-19 immunisation. Medical history was reported as none. There were no concomitant medications. The patient received the first dose of the Pfizer COVID vaccine on 14Mar2021. He tested positive for COVID-19 on 17Mar2021. The patient was scheduled to receive the second dose on 03Apr2021. The patient would like to know if it would be okay to receive the second dose after having a positive diagnosis of COVID-19 after dose one. He was scheduled for the second dose on 03Apr2021 and he just wanted to ask if he is able to receive the second dose on that date. The outcome of the event was unknown.
all happened from 2/22/07-2/25/07 aches-fever-sore throat and passed out-convulsion-crippled rt leg-rt thumb went out of socket
PT RECEIVED  MODERNA VACCINE 1/20/21 (LOT 013L20A) + 2/23/21 (LOT 013M20A). S/O BEGAN 9/02/21, TESTED + 9/3/21
Awoke next day 3/15 @ 5 AM with flu like symptoms. Did not take temperature but had marked chills, nausea, fatigue, backache, both arm sites were sore. Took aspirin. Seen @ 2 PM that day, feeling better, both deltoid areas warm, sore, not red. Was afebrile. Advised ibuprofen. Called him 24 hours later and was feeling much better.
This spontaneous report as received from a nurse practitioner refers to a 12 month old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. No information on patient's concomitant medication was provided. On 15-JAN-2015, the patient was vaccinated with the dose of PEDVAXHIB lot # K008874 (dose, strength, route of administration and expiration date were not reported) which had temperature excursion. This is one of several reports from the same reporter. Additional information has been requested.
Inflamation and redness at the site of the injection; Itchiness at the site of the injection; Inflamation and redness at the site of the injection; Face flush; Experiencing jitters and palpitations of the heart; Heart palpitations; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Face flush), FEELING JITTERY (Experiencing jitters and palpitations of the heart), PALPITATIONS (Heart palpitations), VACCINATION SITE INFLAMMATION (Inflamation and redness at the site of the injection) and VACCINATION SITE PRURITUS (Itchiness at the site of the injection) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced FLUSHING (Face flush), FEELING JITTERY (Experiencing jitters and palpitations of the heart) and PALPITATIONS (Heart palpitations). On 02-Apr-2021, the patient experienced VACCINATION SITE INFLAMMATION (Inflamation and redness at the site of the injection), VACCINATION SITE PRURITUS (Itchiness at the site of the injection) and VACCINATION SITE ERYTHEMA (Inflamation and redness at the site of the injection). On 02-Apr-2021, FLUSHING (Face flush), FEELING JITTERY (Experiencing jitters and palpitations of the heart) and PALPITATIONS (Heart palpitations) had resolved. On 11-Apr-2021, VACCINATION SITE INFLAMMATION (Inflamation and redness at the site of the injection), VACCINATION SITE PRURITUS (Itchiness at the site of the injection) and VACCINATION SITE ERYTHEMA (Inflamation and redness at the site of the injection) had resolved. Not Provided          No relevant concomitant medications were reported. No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable.     This case was linked to MOD21-073269 (E2B Linked Report).; Sender's Comments:  MOD21-073269:cross link
Injection site became hard and itchy, slightly red.  Acts like a mild allergic reaction.  Did not present for quite a while after.
I have had minor tinnitus for years.  It was noticeable when I was going to sleep, but had never bothered me during the day.  After getting my first vaccination it has gotten much worse.  It makes it hard to get to sleep and hard to concentrate on work during the day.
Received first dose on 1/8/21 and second dose on 2/5/21. Mild side effects after first dose (soreness in arm).  During 1st 24 hours of having the 2nd dose I had chills, fever, body aches, sleeplessness. Symptoms subsided within 24-48 hours with the arm soreness taking about a week to completely go away.   A week and a half after receiving the 2nd dose I noticed a lump on my neck, lower middle near the collarbone. It is significantly pronounced. I saw my primary doctor for an already scheduled physical and she said I was fighting off an infection and it was normal. I mentioned I had the COVID vaccine and she said it isn't uncommon to see the lymph node swell after vaccination and it should go away in a couple of weeks. I wanted to report this because it can freak people out to see a lump in their neck so long after being vaccinated without any other symptoms. We need to list this as a possible side effect on the vaccine information. I feel completely fine except my neck is a little tender/sore from the swollen lymph node.
Her arm at the injection site was very swollen and painful. It was also very swollen and painful in the lymph nodes around her armpit.
Patient's eye swelled up and tongue started to tingle several hours after vaccination. Later on he developed myalgia. After ER visit patient was feeling better and swelling was going down.
Rash/redness in arm (large area) pain in arm. 1/24/19 to 1/29/19.
Severe diarrhea and heartburn every day since starting oral Typhoid vaccine. No change after one week after finishing all capsules. Took ZANTAC several days. Did not help.
CONFUSION; DIFFICULTY REMEMBERING NAMES; COVID-19; This spontaneous report received from a patient concerned an 85 year old female of unknown race and ethnicity.   Initial information was processed along with the additional information received on 19-NOV-2021 and 24-NOV-2021. The patient's weight was 127 pounds, and height was 66 inches. The patient's past medical history included: amputation below-knee amputation (bka) left leg, and concurrent conditions included: circulation psoriatic arthritis/ psoriasis, alcoholic (occasional), and non-smoker, and other pre-existing medical conditions included: The patient had no drug abuse or illicit drug usage. Age at the time of vaccination was 84 years. Patient was not pregnant at the time of vaccination. The patient experienced drug allergy when treated with clopidogrel bisulfate.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805022 expiry: Unknown) dose was not reported, 1 total, administered on 10-MAR-2021 (dose number in series 1) for prophylactic vaccination. Patient contracted Covid-19 in May or June. On an unspecified date, the patient experienced confusion, difficulty remembering names (all events dose number in series 1). Patient recently received the Moderna Non-company suspect vaccine (mrna 1273) booster dose (dose number series 2) about 2 weeks ago (batch number: Unknown, expiry: Unknown, form of admin, route of admin, and were not reported) dose was not reported, administered on an unspecified date in 12-NOV-2021, for prophylactic vaccination. Concomitant medications included influenza vaccine (higher dose) for prophylactic vaccination, and Shingrix (varicella zoster vaccine rge (cho)) for prophylactic vaccination. She was reading her Tremfya literature and found the notes about if one is receiving vaccines should not take the Tremfya. Patient reported that she was continued to be confused and had difficulty remembering names since she had Covid-19. She stated it was getting better. She stated she received the booster to make sure to not get again. She talked with her doctor about the confusion and said he reported that patient was fine. Patient also said she was elderly so confusion might be a part of age. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from confusion, difficulty remembering names, and covid-19. This report was non-serious. This report was associated with product quality complaint: 90000202894. The suspected product quality complaint has been confirmed to be the reported allegation was not confirmed and the root cause was determined to be not manufacturing related. based on the PQC evaluation/investigation performed.
Bad headache; Bad pain in the middle part of stomach/pain went to middle of back; Ostomy bag output was really watery; Stomach was as hard as rock; Threw up a couple of times; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Bad pain in the middle part of stomach/pain went to middle of back), POST PROCEDURAL DISCHARGE (Ostomy bag output was really watery), ABDOMINAL RIGIDITY (Stomach was as hard as rock), VOMITING (Threw up a couple of times) and HEADACHE (Bad headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included Ostomy bag placement since an unknown date. Concomitant products included METFORMIN, LINAGLIPTIN (TRADJENTA), VALSARTAN, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), PROBIOTICS NOS, FAMOTIDINE (PEPCID [FAMOTIDINE]), CALCIUM, LEVOTHYROXINE SODIUM (SYNTHROID) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced ABDOMINAL PAIN (Bad pain in the middle part of stomach/pain went to middle of back), ABDOMINAL RIGIDITY (Stomach was as hard as rock) and VOMITING (Threw up a couple of times). 15-Apr-2021, the patient experienced POST PROCEDURAL DISCHARGE (Ostomy bag output was really watery). On 16-Apr-2021, the patient experienced HEADACHE (Bad headache). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) at an unspecified dose and frequency. On 16-Apr-2021, ABDOMINAL PAIN (Bad pain in the middle part of stomach/pain went to middle of back), ABDOMINAL RIGIDITY (Stomach was as hard as rock) and VOMITING (Threw up a couple of times) had resolved. At the time of the report, POST PROCEDURAL DISCHARGE (Ostomy bag output was really watery) and HEADACHE (Bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional treatment details included that doctor advised to stay hydrated.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow-up information received on 12 June 2021 and updated event stop date and outcome On 16-Jun-2021: Follow-up information received on 16-JUNE-2021 contains no new informaton
fever up to 103, chills, aches, malaise, abd pain, vomiting, went to the ER had IVF abnormal labs, + non st elevation MI
Coughing; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), via an unspecified route of administration on 06May2021 as 2nd dose, single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), via an unspecified route of administration on unspecified date as 1st dose, single dose for COVID-19 immunization. On an unspecified, the patient experienced cough. It was reported that, patient got second shot on May the 6th of this year, and patient was wondering after so many weeks and was just coughing. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Initial pregnancy report received from a healthcare professional on 17 October 2012. A 38-year-old female patient, whose medical history and concomitant medications were not reported, had received a first dose of ADACEL vaccine (Lot number: U4421AA, anatomical site of vaccination was not reported) intramuscularly on 16 October 2012. The patient was pregnant during vaccination. The patient's last menstrual period was on 10 April 2012. The patient's estimated date of delivery is 15 January 2013. As of 17 October 2012, the patient had not experienced any adverse events. The patient's health during pregnancy, concomitant medications, medical history and risk factors were not reported. As of 17 October 2012, the patient's outcome was unknown. Follow-up information was received on 03 September 2013 from a health care professional. The patient's last menstrual period was reported as 20 April 2012. Relevant illness during pregnancy/ongoing included chorioamnionitis, PTL (premature labor) and LEEP (Loop electrosurgical excision procedure). Medication use during pregnancy included Tdap, Flu vaccine and terbutaline. According to the reporter, the patient had no adverse events following vaccination. The patient had 2 pregnancies. The end of pregnancy was reported as 04 January 2013 and the infant outcome was normal. List of documents held by the sender none.
(Severe shoulder pain/injury which has been) keeping awake a little at night as well due to uncomfortable sleeping positions; Severe shoulder pain/(injury) following the administration of flu shot; Severe shoulder (pain/)injury following the administration of flu shot; This is a spontaneous case reported by other non-health professional to Agency (reference number: SEQ19-03477) and initially received on 30-Sep-2019, concerning a male patient of unknown age.    The patient's medical history and concomitant medications were not provided.  On 26-Sep-2019, the patient was administered Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent, dose, anatomical location, route of administration, batch number and expiration date: not provided) for influenza prophylaxis.  On an unspecified date in Sep-2019, at unknown time after vaccination, the patient experienced severe shoulder pain/injury. The pain has been keeping him awake a little at night as well due to uncomfortable sleeping positions.     The outcome for the both events was reported as unknown.  The case was assessed as non-serious. The reporter did not provide causality assessment to Flucelvax QIV.; Sender's Comments: The patient experienced insomnia, musculoskeletal pain and shoulder injury related to vaccine administration after vaccination with the suspect product Flucelvax QIV. Chronology is plausible. More information regarding medical history and concomitant drugs is needed. Based on provided information, causal role of the suspect product is assessed as related for all events.
on 8/11/23 I have given the patient the wrong vaccine at 12:42. I overlooked the immunization sheet and have given vaccine sooner than the recommend date.